The Hartford 2014 Annual Report Download - page 198

Table of Contents




The Company enters into various collateral arrangements in connection with its derivative instruments, which require both the pledging and accepting of
collateral. As of December 31, 2014 and 2013, the Company pledged cash collateral associated with derivative instruments with a fair value of $120 and
$347, respectively, for which the collateral receivable has been primarily included within other assets on the Company's Consolidated Balance Sheets. As of
December 31, 2014 and 2013, the Company also pledged securities collateral associated with derivative instruments with a fair value of $1.1 billion and $1.3
billion, respectively, which have been included in fixed maturities on the Consolidated Balance Sheets. The counterparties have the right to sell or re-pledge
these securities.
As of December 31, 2014 and 2013, the Company accepted cash collateral associated with derivative instruments of $327 and $180, respectively, which was
invested and recorded in the Consolidated Balance Sheets in fixed maturities and short-term investments with corresponding amounts recorded in other
liabilities. The Company also accepted securities collateral as of December 31, 2014 and 2013 with a fair value of $109 and $243, respectively, of which the
Company has the ability to sell or repledge $97 and $191, respectively. As of December 31, 2014 and 2013, the fair value of repledged securities totaled $0
and $39, respectively, and the Company did not sell any securities. In addition, as of December 31, 2014 and 2013, non-cash collateral accepted was held in
separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets.
F-62